Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > This is what I was waiting to hear

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Feb 15, 2023 7:14am

145 Views

Post# 35286767

RE:RE:This is what I was waiting to hear

gojotv! wrote: Now that all these diverse experts agree that TLD-1433 is commercially viable, all we need is for the FDA to answer the next question:
Are we gonna do this fast or slow?
Come through, BTD!
Then, AA, and to the moon!
GLTA of us!

For me it's already slow! Hope the pace will accelerate for shareholders but more importantly the patients that need more options. When is the next financial, end of February? GL

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec